Cardiac Precision Medicine represents a cutting-edge approach that tailors cardiovascular care to the unique genetic, molecular, and clinical characteristics of individual patients. By delving into the intricate details of an individual's genetic makeup, lifestyle, and environmental factors, Cardiac Precision Medicine aims to create personalized treatment strategies for cardiovascular conditions. This innovative field harnesses the power of advanced technologies, such as genomics and data analytics, to identify specific genetic variations and biomarkers associated with cardiovascular diseases. The ultimate goal is to enhance the accuracy of diagnosis, predict the risk of cardiovascular events, and optimize treatment outcomes. Cardiac Precision Medicine heralds a new era in cardiovascular healthcare, paving the way for more targeted and effective interventions tailored to the specific needs of each patient.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation